Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether Dabigatran itself reduces ADP induced platelet
aggregation measured by MEA as compared to Phenprocoumon after a two-week treatment with
either agent.